FATE Competitors & Alternatives
Compare Fate Therapeutics Inc with similar stocks in the same industry
Biotechnology
FATE
Main Stock$2.06
Tradestie Score
56
Market Cap
$144.16M
Revenue Growth
0.1%
Analyst Upside
+178.9%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
OMER
Omeros Corporation
|
$16.43
|
$281.75M | 13.6 | 60 | Compare |
|
DBVT
DBV Technologies S.A.
|
$9.66
|
$275.54M | - | 61 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$1.26
|
$275.13M | - | 52 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$18.86
|
$269.08M | 0.1 | 64 | Compare |
|
PBYI
PUMA BIOTECHNOLOGY INC
|
$11.29
|
$265.45M | 21.1 | 39 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 51 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$24.40
|
$256.54M | - | 66 | Compare |
|
SLN
Silence Therapeutics Plc American Depository Share
|
$19.66
|
$240.89M | - | 35 | Compare |
|
OABI
OmniAb, Inc. Common Stock
|
$4.81
|
$231.77M | - | 48 | Compare |
|
SGMT
Sagimet Biosciences Inc. Series A Common Stock
|
$9.71
|
$227.00M | - | 47 | Compare |
More FATE Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2836)
222 stocks in this industry